DECR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DECR Antibodies for research focused on understanding 2,4-dienoyl-CoA reductase (DECR). DECR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 2,4-dienoyl-CoA reductase (DECR) plays a crucial role in fatty acid metabolism, specifically in the peroxisomal β-oxidation pathway. DECR is essential for the breakdown of unsaturated fatty acids, contributing to cellular energy production and lipid homeostasis. Understanding DECR function is vital for elucidating metabolic disorders and developing therapeutic strategies. Researchers can explore DECR's involvement in various cellular processes through detailed molecular analysis. Advanced imaging techniques combined with specific molecular markers allow for precise localization and functional studies of DECR. Investigating DECR's regulatory mechanisms provides valuable insights into metabolic pathway modulation. Santa Cruz Biotechnology monoclonal antibodies for DECR research support scientists worldwide in advancing our understanding of cellular metabolism and disease mechanisms.